Header Logo

Connection

PAUL LING to Humans

Back to Details
This is a "connection" page, showing publications PAUL LING has written about Humans.
PAUL LING
Connection Strength
0.153
Humans
  1. The EBNA-2 N-Terminal Transactivation Domain Folds into a Dimeric Structure Required for Target Gene Activation. PLoS Pathog. 2015 May; 11(5):e1004910.
    View in: PubMed
    Score: 0.014
  2. EBNA2 and Its Coactivator EBNA-LP. Curr Top Microbiol Immunol. 2015; 391:35-59.
    View in: PubMed
    Score: 0.013
  3. Murine gammaherpesvirus 68 ORF75c contains ubiquitin E3 ligase activity and requires PML SUMOylation but not other known cellular PML regulators, CK2 and E6AP, to mediate PML degradation. Virology. 2013 Jun 05; 440(2):140-9.
    View in: PubMed
    Score: 0.012
  4. Epstein-Barr virus BART9 miRNA modulates LMP1 levels and affects growth rate of nasal NK T cell lymphomas. PLoS One. 2011; 6(11):e27271.
    View in: PubMed
    Score: 0.011
  5. Nuclear-cytoplasmic shuttling is not required for the Epstein-Barr virus EBNA-LP transcriptional coactivation function. J Virol. 2009 Jul; 83(14):7109-16.
    View in: PubMed
    Score: 0.009
  6. Regulation of Sp100A subnuclear localization and transcriptional function by EBNA-LP and interferon. J Interferon Cytokine Res. 2008 Nov; 28(11):667-78.
    View in: PubMed
    Score: 0.009
  7. Murine gammaherpesvirus 68 open reading frame 75c tegument protein induces the degradation of PML and is essential for production of infectious virus. J Virol. 2008 Aug; 82(16):8000-12.
    View in: PubMed
    Score: 0.008
  8. Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100. EMBO J. 2005 Oct 19; 24(20):3565-75.
    View in: PubMed
    Score: 0.007
  9. Isolation and immortalization of lymphocytes. Curr Protoc Mol Biol. 2005 May; Chapter 28:Unit 28.2.
    View in: PubMed
    Score: 0.007
  10. The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter. J Virol. 2005 Apr; 79(7):4492-505.
    View in: PubMed
    Score: 0.007
  11. EBNA2 amino acids 3 to 30 are required for induction of LMP-1 and immortalization maintenance. J Virol. 2004 Apr; 78(8):3919-29.
    View in: PubMed
    Score: 0.006
  12. Epstein-Barr virus DNA loads in adult human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy. Clin Infect Dis. 2003 Nov 01; 37(9):1244-9.
    View in: PubMed
    Score: 0.006
  13. Multiple Epstein-Barr virus infections in healthy individuals. J Virol. 2003 Jun; 77(11):6546-50.
    View in: PubMed
    Score: 0.006
  14. The dynamics of herpesvirus and polyomavirus reactivation and shedding in healthy adults: a 14-month longitudinal study. J Infect Dis. 2003 May 15; 187(10):1571-80.
    View in: PubMed
    Score: 0.006
  15. The EBNA2 polyproline region is dispensable for Epstein-Barr virus-mediated immortalization maintenance. J Virol. 2002 Jul; 76(14):7349-55.
    View in: PubMed
    Score: 0.006
  16. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART. J Med Virol. 2002 Jul; 67(3):320-6.
    View in: PubMed
    Score: 0.006
  17. Conserved regions in the Epstein-Barr virus leader protein define distinct domains required for nuclear localization and transcriptional cooperation with EBNA2. J Virol. 2000 Nov; 74(21):9953-63.
    View in: PubMed
    Score: 0.005
  18. First Days in the Life of Naive Human B Lymphocytes Infected with Epstein-Barr Virus. mBio. 2019 09 17; 10(5).
    View in: PubMed
    Score: 0.005
  19. Characterization of the CBF2 binding site within the Epstein-Barr virus latency C promoter and its role in modulating EBNA2-mediated transactivation. J Virol. 1998 Jan; 72(1):693-700.
    View in: PubMed
    Score: 0.004
  20. Human cytomegalovirus infection causes degradation of Sp100 proteins that suppress viral gene expression. J Virol. 2011 Nov; 85(22):11928-37.
    View in: PubMed
    Score: 0.003
  21. Expression of Epstein-Barr virus latent genes in oral epithelium: determinants of the pathogenesis of oral hairy leukoplakia. J Infect Dis. 2004 Jul 15; 190(2):396-9.
    View in: PubMed
    Score: 0.002
  22. Generation of EBV-specific CD4+ cytotoxic T cells from virus naive individuals. J Immunol. 2002 Jan 15; 168(2):909-18.
    View in: PubMed
    Score: 0.001
  23. Regulation of the Epstein-Barr virus C promoter by AUF1 and the cyclic AMP/protein kinase A signaling pathway. J Virol. 2000 Sep; 74(17):8166-75.
    View in: PubMed
    Score: 0.001
  24. Evolution of two types of rhesus lymphocryptovirus similar to type 1 and type 2 Epstein-Barr virus. J Virol. 1999 Nov; 73(11):9206-12.
    View in: PubMed
    Score: 0.001
  25. Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa. Science. 1994 Jul 01; 265(5168):92-5.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.